European co-host session: Inequity in cancer, a European perspective - How do we measure inequities in cancer?

European co-host session: Inequity in cancer, a European perspective - How do we measure inequities in cancer?

Plenary F
European co-host session

Information

Session co-organised by The Swedish Cancer Society (Sweden), World Health Organization (WHO) (Switzerland), and the International Agency for Research on Cancer (IARC) (France) Chaired by: Ulrika Kågström, Swedish Cancer Society - Cancerfonden (Sweden)

Presentations:

1. Welcome and introduction Ulrika Kågström, Swedish Cancer Society - Cancerfonden (Sweden)


2. WHO Europe report: Healthy, prosperous lives for all: the European Health Equity Status Report María Lasierra Losada (WHO)

3. IARC-report: Reducing Social Inequalities in Cancer: Evidence and Priorities for Research Salvatore Vaccarella, International Agency for Research On Cancer (IARC) (France)

4. Presentation from Denmark on national data report Jesper Fisker, Danish Cancer Society (Denmark)

5. Title TBC Claire Kilty, Irish Cancer Society (Ireland)

6. Panel discussion followed with Q&A with the audience

7. Closing remarks Vitaly Smelov, WHO Europe



Description:

Cancer occurrences, causes, outcomes and control measures differ markedly within countries in Europe. However, these differences are not neutral in nature but instead frequently reflect social inequalities in the distribution of cancer risk factors and access to prevention measures, early detection, treatment, and care, with a consequent impact on survival and quality of life after a cancer diagnosis. This session aims to raise awareness of these inequities and be the starting point of a discussion about how these can be addressed.

Session code
EU1
CancerfondenABOUT CANCERFONDEN The Swedish Cancer Society is an independent, non-profit fundraising organization that has provided financial conditions for cancer research since 1951. The Swedish Cancer Society work to beat cancer sooner through financing the best cancer research in Sweden. The goal is that fewer people in Sweden will be affected by cancer and more will survive. THIS IS HOW WE BEAT CANCER We finance research We finance the best cancer research in the country. To ensure high quality research our Research Commission consists of highly esteemed researchers. We fundraise Thanks to our donors we can work to save more lives. We fundraise through a wide range of campaigns and platforms, donor communications and collaborations with companies. We inform & support We strive to inform and support everyone affected by cancer, both those with cancer and next of kin, by spreading information about cancer, treatments and research as well as through our support line. We make change happen Politics plays an important role in the fight to beat cancer and our advocacy work is very important. The politicians decide the preconditions for prevention, health care and research. OUR IMPACT • We have contributed with 13 billion SEK to Swedish cancer research since the start 70 years ago. • 80 % of the national healthcare programs refer to research funded by the Swedish Cancer Society. • Today, two out three survive cancer in Sweden. 70 years ago that number was one out of three. Largest charity in Sweden Thanks do all of our donors we can fund over 500 research projects every year. Being the largest fundraising charity in Sweden we get donations via legacies, monthly giving, donations and memorial gifts as well as peer-to-peer fundraisers, corporate donations and partnerships. During 2021 our total revenue was 949 million SEK, which was the highest ever. OUR GOALS 2030 • Reduce preventable cancer cases by 30 % • A third of all cancers are diagnosed at an earlier stage • 80 % survive a cancer diagnosis • Everyone has the best possible quality of life, both during and after cancer Highlighted reports The Swedish Cancer Socitey's report health care 2021 – segregated screening There are clear geographical differences in the degree of participation in the national screening programs for breast cancer, cervical cancer and colorectal cancer. This is true both between and within regions. Read the report How COVID-19 impacted cancer research in Sweden – 2021 The purpose of this report is to identify how the COVID-19 pandemic has impacted Swedish cancer research. Read the report How Covid-19 is affecting cancer care in Sweden – 2020 In this 2020-report one of the findings were that cancer treatments to a large extent were taking place as usual. Read the report

Registered attendees

AZ
Adam Zerda
Sr. Director International AffairsBD (Becton Dickinson)
Adrian Ritter
Adrian Ritter
dipl. Journalistvarious publications in the medical field
AH
Ahmed Hefnawy
Obstetrics & Gynaecology specialist traineeNottingham University Hospitals, United Kingdom (Queens Medical Center)

Log in